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Abstract: Ovarian Toxicity of 2-Bromopropane in the Non-Pregnant
Female Rat: Michihiro KAMIJIMA, et al. Department of Hygiene, Nagoya University School of Medicine-A cluster of patients with amenorrhea, oligospermia and anemia were found among workers in an electronics factory in the Republic of Korea. 2-Bromopropane was suspected to cause the disorders. This study aimed to clarify its ovarian toxicity in the virgin rat. Female Wistar rats were daily exposed to 0, 100, 300, or 1,000 ppm 2-bromopropane for eight hours a day for 9 weeks. During the experimental period, vaginal smears were taken everyday to monitor ovarian cyclicity. Tissues were histopathologically examined and plasma concentrations of luteinizing hormone (LH) and folliclestimulating hormone (FSH) were determined at the end of experiment. The vaginal smear test showed that the number of normal cycles decreased significantly both in the 300 and 1,000 ppm groups. The histopathological examination revealed dose-dependent ovarian follicle atresia accompanied by a decreased number of normal antral and growing follicles in the 300 and 1,000 ppm groups. Especially, in the ovaries of rats with persistent estrous smears in the 1,000 ppm group, most of the follicles were atretic and there were no newly formed corpora lutea. There still remained normal antral follicles and corpora lutea in the ovaries of the remaining rats of the group and of the 300 ppm group with constant diestrous and occasional estrous smears.
Hormonal examination revealed no statistically significant change in LH or FSH concentrations between any groups. The results showed that 2-bromopropane has ovarian toxicity in rats, indicating that the secondary amenorrhea in human cases was due to 2-bromopropane exposure. In 1995, a cluster of patients with amenorrhea, oligospermia and anemia were found among workers in an electronics factory in the Republic of Korea. The workers affected were all exposed to 2-bromopropane-containing solvents. 2-Bromopropane was used as an alternative to ozone layer-depleting freon. Though neither reproductive nor hematopoietic toxicity of the solvent had been reported before that, 2-bromopropane was considered as the most probable cause of the disorders from a cross-sectional survey'). Thus, animal experiments were conducted to clarify the toxicity of 2-bromopropane.
Our first study in male rats showed that 2-bromopropane impaired spermatogenesis and hematopoiesis dose-dependently2.31. The second study in female rats revealed that 2-bromopropane disrupted estrous cyclicity, which we reported in the preliminary paper'). In the present paper, we extensively clarified that 2-bromopropane has ovarian toxicity in the virgin rat.
Materials and Methods
Chemical: 2-Bromopropane (99.4% purity) was obtained from Tosoh Co., Japan.
Animals: Female rats (slc: Wistar/ST) were obtained from SLC (Shizuoka Laboratory Animal Center, Japan). Animals were housed in stainless steel chambers, provided food and water ad libitum, and maintained under controlled conditions of light (12-hr/12-hr, light/dark cycle, lights off at 9:00 PM), temperature (22-25°C) and humidity (57-60%). Japanese law concerning the protection and control of animals, the standards relating to the care and management of experimental animals, and the Animal Experimental Guide of Nagoya University School of Medicine were followed in this experiment.
Animal treatments: Thirty-six rats, weighing 230-270 g at 12 weeks of age, were divided into four groups of nine after acclimatizing them to conditions. After monitoring pretreatment estrous cycle in every rat for three weeks, each group was daily exposed to 0, 100, 300, or 1,000 ppm 2bromopropane for eight hours a day (from 2:00 to 10:00 PM) in the chambers. These concentrations were selected according to our previous study on male rats, in which all rats exposed at 3,000 ppm 2-bromopropane became seriously ill and spermatogenesis was impaired at 300 ppm or more''. The inhalation exposure system has been described in detail elsewhere; 5). Vapor concentrations were measured with gas chromatography and controlled to be within ± 5% of the target concentrations by a personal computer system. During the experimental period, vaginal smears were taken every day to monitor ovarian cyclicity, and all the rats were weighed once every week. After the exposure for 9 weeks, the rats were decapitated on the day of diestrus I during the 10th week. Blood was collected for hormonal assay. Organs were removed and weighed immediately and fixed in 10% neutral-buffered formalin for light microscopic evaluation. When the smears showed disrupted estrous cyclicity, i.e. constant estrus or constant diestrus, the rats were sacrificed on the day of estrus or diestrus, respectively. The exposure was continued until the day before autopsy.
Vaginal smears: Daily vaginal smears were taken between 10:00 and 11:00 Am'). They were stained with methylene blue (Katayama Chemical, Japan) solution and observed under a microscope. The 12-week experimental period was divided into four consecutive 3-week periods, one preexposure period and three exposure periods. Then the number of normal estrous cycles that started with smears characteristic of estrus was counted in each rat throughout the periods. The cycles were regarded as normal when they showed typical stages of proestrus, estrus and diestrus6•'), which was usually observed with a four-to six-day cycle. When a cycle extended from one period to another, the cycle was counted as 0.5 cycle in each period.
Tissue preparation: After fixation, tissues were dehydrated in graded concentrations of alcohol, embedded in paraffin, sectioned at 6 pin, then stained with hematoxylineosin.
Hormonal assay: Concentrations of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in 50 pd plasma samples were determined by a double-antibody radioimmunoassay (RIA) using rat LH and FSH RIA kits supplied by the National Hormone and Pituitary Program (Baltimore, MD). The values were expressed in terms of NIDDK-rLH-RP-3 and NIDDK-rFSH-RP-2, respectively. The least detectable levels of LH and FSH were 0.16 ng/ml and 2.5 ng/ml, respectively.
Data analysis: The rats without regular estrous cycles during the pre-exposure period were discarded from the analysis for estrous cycle, organ weight, and hormonal concentration.
One rat in the 300 ppm group was also discarded from the analysis for organ weight and hormonal concentration because the rat did not have the left kidney, left ovary, or left uterine horn. The differences in body weight, organ weight, and hormonal concentration between the exposed groups and the control group were analyzed by ANOVA followed by Dunnett's multiple comparison method. The number of estrous cycles after exposure was compared to that before exposure by Kruskal-Wallis test followed by Dunnett-type multiple comparison method. Fig. 1 . Change in body weight. After monitoring the estrous cycle for three weeks, each group was daily exposed to 0, 100, 300, or 1,000 ppm 2-bromopropane for 8 hours a day, for 9 weeks. Each point is the mean. *Significantly different from the control group (p<0 .05 by Dunnett's multiple comparison).
Results
The vapor concentrations in exposed groups were 1,025 ± 34 ppm, 299 ± 9 ppm, and 98 ± 3 ppm (mean ± S.D.), respectively. All the animals survived until the end of the experiment. The rats in the 1,000 ppm group did not move around in the cage as much as those in other groups during the exposure period. Muscle tonus gradually decreased in the 1,000 ppm group, and body weight gain in the group was significantly suppressed compared to the control group.
Body weights of the other two groups did not significantly differ from the control (Fig. 1) .
The vaginal smear test showed that the estrous cycles in the 1,000 ppm group began to prolong around the 2nd week of exposure, and the number of normal cycles decreased significantly in the last two periods ( Table 1) . During the periods, five rats in the group displayed constant diestrous smears with occasional estrous ones, while the remaining four rats in the group had constant estrous smears with occasional diestrous ones. In the 300 ppm group, the estrous cycles were gradually prolonged around the 7th week resulting from the prolonged diestrus. During the last period, all the rats displayed constant diestrus with occasional estrus. The average interval of the estrous days in the period was 12.4 days in this group. In the 100 ppm group, there was no significant change in the number of normal cycles ( Table  1) .
Analysis of organ weights revealed that the ovary weight tended to decrease in the 1,000 ppm group. The weight of uterus did not change significantly (Table 2 ). However, when compared among the rats autopsied on the day of diestrus, the uterine weight significantly decreased in the 300 and 1,000 ppm groups compared to the control group (Table 3 ). The histopathological examination revealed no abnormal findings in organs other than those of the reproductive system. In the 1,000 ppm group, the most remarkable change in the ovaries was widespread ovarian follicle atresia accompanied by a decreased number of normal antral and growing follicles. In particular, in the ovaries of the four persistent estrous rats, most of the follicles were atretic and viable oocytes were hardly found in the remaining follicles. Thin layers of granulosa cells were sometimes maintained in the remaining cystic follicles. There were no newly formed corpora lutea. On the other hand, normal antral follicles and corpora lutea remained in the other five rats of constant vaginal diestrus with occasional estrus. However , the number of antral and growing follicles was considerably fewer than in the control. Ovaries of the rats in the 300 ppm group displayed changes similar to those in the ovary of the rats with constant diestrous smears in the 1,000 ppm group (Fig. 2) .
Hormonal examination revealed no statistically significant change in plasma LH or FSH concentrations between any groups. However, LH tended to decrease dose-dependently and FSH to increase dose-dependently in the 300 and 1,000 ppm groups (Tables 4, 5 ). Table 3 . Body weights and reproductive organ weights in the rats which showed diestrous smears on the day of autopsy
Relative organ weights are expressed in mg tissue weight/g body weight and indicated in parentheses. *p<0.05, **p<0.01.
Discussion
The present study showed damage to the ovary and the resulting disruption in estrous cyclicity due to 2bromopropane exposure at 300 ppm and 1,000 ppm in nonpregnant female rats. Although the rats exposed to 100 ppm of 2-bromopropane did not show a significant decrease in the number of normal estrous cycles as a whole, it seems plausible that longer exposure at 100 ppm could cause significant effects because it took about 7 weeks to detect the effect of exposure at 300 ppm.
There were two types of disruption in the cyclicity of rats in the 1,000 ppm group. In one type, the rats showed constant vaginal estrus without viable follicles and corpora lutea in the ovary, which was indicative of anovulation; in the other, we found constant diestrus and occasional estrus with decreased viable follicles and corpora lutea, which was similar to "repetitive pseudopregnancies"6) and indicative of a decreased number of ovulations. These two patterns might be explained in terms of the extent of ovarian damage and the cycle of follicular development. Conceivably, 2bromopropane not only damages oocytes but interferes with follicular maturation. The partial loss of oocytes and delayed follicular maturation would result in the prolonged diestrus and the decrease in the number of ovulations and corpora lutea. The severer damage to oocytes would lead to follicular atresia and cessation of development of antral follicles. The underdevelopment of the antral follicles would result in a condition in which the blood concentration of estrogen would not increase enough to cause the LH surge which is critical for ovulation and corpora lutea formation. On the other hand, once the LH surge and the resulting formation of corpora lutea occur, the insufficient estrogen production from the next follicles would prevent corpora lutea from diminishing. In fact, the dose-dependent decrease in the uterine weight among the diestrous rats indicated the suppression of estrogen production in the rats of the 300 and 1,000 ppm group.
Interestingly, the plasma concentration of FSH did not rise significantly despite the severe damage to the ovaries. The similar phenomenon was also observed in rats treated with an antineoplastic alkylating agent, cyclophosphamide, which suggested that the mechanism of ovarian toxicity was different from that by irradiation inducing high concentration of serum LH and FSHB).
As for reproductive toxicity of other halogenated propanes, 1,2-dibromo-3-chloropropane (DBCP) is known as a potent testicular toxicant9). However, the information on female reproductive toxicity induced by DBCP or other halogenated propanes is still scarce. One study reported that DBCP was not likely to affect oogenesis and ova in (c-2) 1,000 ppm: The ovary in persistent estrous rats consisted mainly of tissues derived from atretic follicles. Viable oocytes were not found in the remaining cystic follicles. There were no newly formed corpora lutea. (Hematoxylin-Eosin staining; original magnification x 125.) Table 4 . Plasma concentrations of luteinizing hormone (LH) and follicle stimulating hormone (FSH) in rats exposed to 2-bromopropane for 9 weeks Table 5 . Plasma concentrations of LH and FSH in the rats which showed diestrous smears on the day of autopsy contrast to the effect on spermatogenesis". Extensive studies are needed on female reproductive toxicity of structurally related compounds, especially in a chronic or subchronic study design.
In conclusion, 2-bromopropane is as toxic to the female reproductive system as it is to the male's. The amenorrhea observed among Korean workers in an electronics factory') could be primarily attributable to 2-bromopropane exposure .
